IP Library Granted Patent US 10,004,771
Granted Patent B2
US 10,004,771 · App. 15/484,842 · Granted Jun 26, 2018

Method of identifying a biologically-active composition from a biofilm

Inventors: Eva A. Berkes (Sarasota, FL); Nicholas T. Monsul (Sarasota, FL); Frederick T. Boehm (Sarasota, FL)
Assignee: QUORUM INNOVATIONS, LLC
A61K35/747A01N63/02A61K8/34A61K8/99A61K9/0014A61K47/10A61Q19/007A61Q19/10C12N1/20C12Q1/04G01N2333/315G01N2333/335
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,004,771
App. No.
15/484,842
Granted
Jun 26, 2018
Kind
B2
Abstract

The subject invention provides materials and methods that effectively support innate immunity and/or disperse pathogenic biofilms using readily available, nontoxic, natural substances, while supporting restoration of normal microbiotic homeostasis. In one embodiment, the subject invention provides anti-biofilm compositions comprising one or more probiotic organisms, anti-microbial honey, and other ingredients such as prebiotic compounds, other hive products, green tea derivatives, other plant derivatives, and vitamin D3.

Claims (13)

1. A composition for oral consumption comprising a biologically-active composition, wherein the biologically-active composition is obtained by a method comprising the steps of:

(a) growing biofilm cellular mass, which has biological activity, in a biological growth medium;

(b) rendering said biofilm cellular mass non-viable;

and

(c) combining said non-viable biofilm cellular mass with an edible material to form said edible composition that comprises said non-viable biofilm cellular mass, wherein the microbe is a Lactobacillus.

2. The composition, according to claim 1 , wherein the biological activity of said biofilm cellular mass is anti-microbial activity or anti-inflammatory activity.

3. A composition for oral consumption comprising non-viable biologically-active biofilm cellular mass and further comprising an edible material, wherein the microbe is a Lactobacillus.

4. The composition, according to claim 3 , which is a probiotic composition.

5. The composition, according to claim 3 , wherein the composition is formulated for human consumption.

6. The composition, according to claim 3 , wherein the biological activity of said biofilm cellular mass is anti-microbial activity and/or anti-inflammatory activity.

7. The composition, according to claim 3 , comprising a biosurfactant produced by the biofilm.

8. The composition, according to claim 3 , wherein the edible material comprises ingredients that are generally regarded as safe (GRAS).

9. The composition, according to claim 3 , comprising one or more components selected from prebiotics, hive products, plant derivatives and vitamin D3.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 13, 2025
From: QUORUM INNOVATIONS, LLC
To: QUORUM INNOVATIONS, INC.
Reel/Frame 072547/0227 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 20, 2017
From: BERKES, EVA A.; MONSUL, NICHOLAS T.; BOEHM, FREDERICK T.
To: QUORUM INNOVATIONS, LLC
Reel/Frame 042754/0504 →
Continuity (7)
Continuation 15412712 · Jan 23, 2017
Continuation 15349371 · Nov 11, 2016
Continuation 15349420 · Nov 11, 2016
Continuation 13503325 · May 31, 2012
Continuation 13503325
Provisional Application 61447735 · Mar 1, 2011
Related Publication 20170216377A1 · Aug 3, 2017
Cited By (1)
US 12,342,826